Indacaterol in Heart Failure Patients: Any Role on Lung Fluid Regulation
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are:
1. To confirm safety of Indacaterol in stable Heart Failure.
2. To determine whether beta 2 alveolar receptor stimulation by Indacaterol is able to
ameliorate lung diffusion in heart Failure patients treated with beta blockers.
3. To compare the effects of Indacaterol in patients treated with a non-selective beta
blocker (Carvedilol) and a beta 1-selective beta blocker (Bisoprolol).